More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

Chief Executive Officer Appointment

Nov 13, 2018 at 9:44 PM EST · Issued by Anatara Lifesciences Ltd

Filed with ASX · Nov 13, 2018 at 9:44 PM EST

On 6ix: 6ix.com/news/chief-executive-officer-appointment-18

Anatara Lifesciences Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anatara Lifesciences Ltd on 6ix

Story so far

  • Anatara CEO announces retirementMay 17, 2018

Earlier from Anatara Lifesciences

  • APVMA approval for DetachOct 28, 2018
  • Appendix 4E & Audited Financial StatementsAug 31, 2018
  • Investor Presentation and Strategy UpdateJul 18, 2018
  • Anatara CEO announces retirementMay 16, 2018
  • Exclusive Global License Agreement with ZoetisMay 15, 2018

Later from Anatara Lifesciences

  • R&D Tax Refund ReceivedJan 13, 2019
  • Successful proof of concept studiesFeb 7, 2019
  • Response to ASX Appendix 4C QueryFeb 19, 2019
  • Anatara retains global market for DetachJun 13, 2019
  • Anatara Animal Health Asset UpdateJun 28, 2019
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer